Hideki Ebihara Selected Research

Ebola virus nucleoprotein VP35

7/2013

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideki Ebihara Research Topics

Disease

29	Infections 01/2022 - 07/2006
7	Vesicular Stomatitis 10/2015 - 01/2003
6	Virus Diseases (Viral Diseases) 01/2021 - 06/2010
5	Ebola Hemorrhagic Fever 01/2013 - 01/2007
4	COVID-19 01/2021 - 01/2021
4	Fever (Fevers) 01/2013 - 01/2007
3	Disease Progression 06/2013 - 03/2007
3	Filoviridae Infections 12/2010 - 10/2006
2	Human Influenza (Influenza) 01/2021 - 10/2015
1	Severe Acute Respiratory Syndrome 01/2022
1	Orthomyxoviridae Infections 01/2022
1	Breakthrough Infections 01/2022
1	Coronavirus Infections 01/2021
1	Viral Pneumonia 01/2021
1	Asymptomatic Infections 01/2017
1	Viremia 10/2015
1	Marburg Virus Disease 10/2015
1	Encephalitis (Encephalitis, Rasmussen) 04/2013
1	Lassa Fever (Fever, Lassa) 02/2012
1	Pathologic Processes 09/2011
1	Necrosis 08/2011
1	Neoplasms (Cancer) 08/2011
1	Hantavirus Infections 06/2010
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2003

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 09/2011
9	Glycoproteins (Glycoprotein)IBA 10/2015 - 01/2003
8	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2006
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
5	InterferonsIBA 01/2021 - 07/2006
4	CytokinesIBA 01/2017 - 02/2011
3	Neutralizing AntibodiesIBA 01/2022 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2007
2	AntibodiesIBA 01/2019 - 11/2007
2	RNA (Ribonucleic Acid)IBA 01/2019 - 09/2015
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017 - 12/2011
2	RestonIBA 01/2017 - 01/2012
2	ChemokinesIBA 01/2017 - 11/2011
2	EnzymesIBA 10/2015 - 05/2010
2	Nucleocapsid ProteinsIBA 05/2010 - 07/2006
2	Monoclonal AntibodiesIBA 01/2007 - 01/2003
1	Disinfectants (Biocides)IBA 01/2022
1	Dihydroorotate DehydrogenaseIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2021
1	UbiquitinIBA 01/2021
1	ParaffinIBA 01/2021
1	CateninsIBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Interferon LambdaIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2015
1	Combined VaccinesIBA 10/2015
1	Hemagglutinins (Hemagglutinin)IBA 10/2015
1	human IFIT1 proteinIBA 09/2015
1	Ebola virus nucleoprotein VP35IBA 07/2013
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 02/2012
1	Dystroglycans (Dystroglycan)IBA 02/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2012
1	CarbohydratesIBA 02/2012
1	IonsIBA 02/2012
1	Virulence Factors (Pathogenicity Factors)IBA 01/2012
1	Viral AntigensIBA 12/2011
1	Ebola VaccinesIBA 11/2011
1	Synthetic Vaccines (Recombinant Vaccines)IBA 11/2011
1	Metalloproteases (Metalloproteinases)IBA 09/2011
1	Interleukin-1 (Interleukin 1)IBA 08/2011
1	LipopolysaccharidesIBA 05/2011
1	Ribavirin (Virazole)FDA LinkGeneric 01/2011
1	C-Type Lectins (C-Type Lectin)IBA 12/2010
1	Polysaccharides (Glycans)IBA 12/2010
1	Interferon Type IIBA 06/2010
1	RNA Helicases (RNA Helicase)IBA 06/2010
1	ImmunosorbentsIBA 05/2010
1	Amino Acids FDA Link 05/2010
1	NucleoproteinsIBA 11/2007
1	Antisense RNA (Anti-Sense RNA)IBA 11/2007
1	Complement System Proteins (Complement)IBA 11/2007
1	Fc Receptors (Fc Receptor)IBA 11/2007
1	EpitopesIBA 11/2007
1	Small Interfering RNA (siRNA)IBA 11/2007
1	enhanced green fluorescent proteinIBA 11/2007
1	FurinIBA 03/2007
1	RibonucleoproteinsIBA 07/2006

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 01/2011